Experts discuss regulatory approaches for AI and current industry practices
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesEuropePharmaceuticalsProduct LifecycleRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesEuropePharmaceuticalsProduct Lifecycle